Skip to Content

Colloquia

Printer-friendly PDF version
MSL/CHiBi Colloquia will typically take place on the second Tuesday of the month. This is equivalent to a “rolling retreat” in which MSL and CHiBi lab members present their research to the department’s personnel. The goal is to inform, get critical feedback, stimulate exchange of ideas and methods, spark collaboration, provide students with experience in presenting seminars. Three trainees will present from different labs and disciplines followed by refreshments and snacks in the atrium. All Colloquia take place in the MSL lecture theatre on the main floor. Click the title to view full event details.
  • November 16, 2017 - 2:00pm
    Key Speaker: Dr. Andrew Niles, Sr. Research Scientist - Advanced Technology Group Leader, Promega Corp
  • November 6, 2017 - 5:30pm
    How has the work of a Canadian cancer researcher helped to advance our knowledge of cancer and improve outcomes for cancer patients?
    Dr. Connie Eaves, FRS(C) - Distinguished Scientist, Terry Fox Laboratory, BC Cancer Agency & Professor, Department of Medical Genetics, University of British Columbia
  • October 23, 2017 - 3:30pm
    Protein Levels and Neuropsychiatric Disorders: Insights and Opportunities
    Dr. Huda Zoghbi, 2017 Canada Gairdner International Award Recipient - Professor, Baylor College of Medicine; Investigator, Howard Hughes Medical Institute
    CRISPR-Cas systems: from adaptive immunity to genome editing machines
    Dr. Rodolphe Barrangou, 2016 Canada Gairdner International Award Recipient - Assoc Professor, Bioprocessing and Nutrition Sciences, North Carolina State University
  • October 11, 2017 - 8:30am
    Autophagy and Neurodegeneration
    Dr. David Rubinsztein, FMedSci FRS - University of Cambridge
    Autophagy and Mitochondrial Dysfunction in Cancer
    Dr. Kay Macleod, PhD - The University of Chicago
  • June 5, 2017 - 12:00pm
    Keynote: Stem Cells in Human AML
    Dr. Ravi Majeti - Associate Professor of Medicine, Division of Hematology, Cancer Institute, and Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine
Syndicate content